The viral hepatitides.
Vaccines and chemotherapy may soon strengthen the armamentarium for control of type B hepatitis. The incidence of type A is still declining in the U.S., and now that type non-A, non-B has been transmitted to animals, a marker for it is being widely sought.
D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000209:etiology; D004279:DNA, Viral / Q000032:analysis; D006506:Hepatitis A / Q000517:prevention & control / Q000635:transmission; D006509:Hepatitis B / Q000188:drug therapy / Q000517:prevention & control / Q000635:transmission; D006515:Hepatitis B virus / Q000032:analysis; D006525:Hepatitis, Viral, Human / Q000150:complications / Q000628:therapy* / Q000635:transmission; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007136:Immunoglobulins / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000209:etiology; D014611:Vaccination
D004279:DNA, Viral; D007136:Immunoglobulins; D007372:Interferons